Recent advances in cardiovascular development: Promise for the future

Cardiovascular Research

Volumn 40, Issue 3, 1998, Pages 456-468

  Baldwin, H Scott ^a   Artman, Michael ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL GROWTH; CONGENITAL HEART MALFORMATION; DEVELOPMENTAL DISORDER; ELECTROPHYSIOLOGY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE EXPRESSION; HEART DEVELOPMENT; HUMAN; MORPHOGENESIS; PRIORITY JOURNAL; REVIEW; SODIUM CALCIUM EXCHANGE;

ANIMALS; CARDIOVASCULAR SYSTEM; ELECTROPHYSIOLOGY; EMBRYONIC AND FETAL DEVELOPMENT; HEART; HUMANS; MORPHOGENESIS; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; NEURAL CREST;

EID: 0032402819     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00277-6     Document Type: Review

References (95)

1. Artman M., Nakanishi T., Rosen M. Editorial commentary: Developmental cardiology enters adolescence. Cardiovasc Res. 31:1996;E1.
2. Fishman M.C., Chien K.R. Fashioning the vertebrate heart: earliest embryonic decisions. Development. 124:1997;2099-2117.
3. Fishman M.C., Olson E.N. Parsing the heart: genetic modules for organ assembly. Cell. 91:1997;153-156.
4. Franco D., Lamers W.H., Moorman A.F.M. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc Res. 38:1998;25-53.
5. Sucov H.M. Molecular insights into cardiac development. Annu Rev Physiol. 60:1998;287-308.
6. Supp D.M., Brueckner M., Potter S.S. Handed asymmetry in the mouse: understanding how things go right (or left) by studying how they go wrong. Semin Cell Devel Biol. 9:1998;77-87.
7. Levin M., Mercola M. The compulsion of chirality: toward an understanding of left-right asymmetry. Genes Devel. 12:1998;763-769.
8. Supp D.M., Witte D.P., Potter S.S., Brueckner M. Mutation of an axonemal dynein affects left-right asymmetry in inversus viscerum mice. Nature. 389:1997;963-966.
9. Brueckner M., D'Eustachio P., Horwich A.L. Linkage mapping of a mouse gene, iv, that controls left-right asymmetry of the heart and viscera. Proc Natl Acad Sci USA. 86:1989;5035-5038.
10. Singh G., Supp D.M., Schreiner C.et al. Legless insertional mutation: morphological, molecular, and genetic characterization. Genes Devel. 5:1991;2245-2255.
11. Ryan A.K., Blumberg B., Rodriguez-Esteban C.et al. Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature. 394:1998;545-551.
12. Logan B., Pagan-Westphal S., Smith D., Paganesi L., Tabin C.J. The transcription factor of Ptx-2 mediates situs-specific morphogenesis in response to left-right asymmetric signaling. Cell. 94:1998;307-318.
13. Srivastava D., Thomas T., Lin Q.et al. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nature Genet. 16:1997;154-160.
14. Thomas T., Yamagishi H., Overbeek P.A., Olson E.N., Srivastava D. The bHLH factors, dHAND and eHAND specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. Devel Biol. 196:1998;228-236.
15. Yokoyama T., Copeland N.G., Jenkins N.A.et al. Reversal of left-right asymmetry: a situs inversus mutation. Science. 260:1993;679-682.
16. Evans T. Regulation of cardiac gene expression by GATA4/5/6. Trends Cardiovasc Med. 7:1997;75-83.
17. Molkentin J.D., Lu J.R., Antos C.L.et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
18. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., Keller G. A common precursor for hematopoietic and endothelial cells. Development. 125:1998;725-732.
19. + cells at a diverging point of endothelial and hemopoietic lineages. Development. 125:1998;1747-1757.
20. Hartzopoulos A.K., Folkman J., Vasile E., Eiselen G.K., Rosenberg R.D. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development. 125:1998;1457-1468.
21. Asahara T., Murohara T., Sullivan A.et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:1997;964-967.
22. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 277:1997;48-50.
23. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
24. Baldwin HS. Molecular determinants of embryonic vascular development. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. 2nd ed. Philadelphia: W.B. Saunders Co., 1998, pp. 801-813.
25. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis? Cell. 87:1996;1153-1155.
26. Carmeliet P., Collen D. Genetic analysis of vessel formation: Role of endothelial versus smooth muscle cells. Trends Cardiovasc Med. 7:1997;271-281.
27. DeRuiter M.C., Poelmann R.E., VanMunsteren J.C.et al. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res. 80:1997;444-451.
28. Majesky M.W., Schwartz S.M. An origin for smooth muscle cells from endothelium? Circ Res. 80:1997;601-603.
29. Davis S., Aldrich T.H., Jones P.F.et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169.
30. Suri C., Jones P.F., Patan S.et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
31. Vikkula M., Boon L.M., Carraway K.L.et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase Tie2. Cell. 87:1996;1181-1190.
32. Alon T., Hemo I., Itin A.et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1:1995;1024-1028.
33. Benjamin L.E., Hemo I., Keshet E. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 125:1998;1591-1598.
34. Maisonpierre P.C., Suri C., Jones P.F.et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
35. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
36. Yancopoulos G.D., Klagsbrun M., Folkman J. Vasculogenesis, angiogenesis and growth factors: ephrins enter the fray at the border. Cell. 93:1998;661-664.
37. Flanagan J.G., Vanderhaeghen P. The ephrins and Eph receptors in neural development. Ann Rev Neurosci. 21:1998;309-345.
38. Wang H.U., Chen Z.F., Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:1998;741-753.
39. Ranger A.M., Grusby M.J., Hodge M.R.et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 392:1998;186-190.
40. de la Pompa J.L., Timmerman L.A., Takimoto H.et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 392:1998;182-186.
41. Nolan G.P. Cardiac development. Transcription and the broken heart. Nature. 392:1998;129-130.
42. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Ann Rev Immunol. 15:1997;707-747.
43. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res. 77:1995;1-6.
44. Carraway K.L. Involvement of the neuregulins and their receptors in cardiac and neural development. Bioessays. 18:1996;263-266.
45. Tessarollo L., Hempstead B.L. Regulation of cardiac development by receptor tyrosine kinases. Trends Cardiovasc Med. 8:1998;34-40.
46. Meyer D., Birchmeier C. Multiple essential functions of neuregulin in development. Nature. 378:1995;386-390.
47. Kramer R., Bucay N., Kane D.J.et al. Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc Natl Acad Sci USA. 93:1996;4833-4838.
48. Lee K.F., Simon H., Chen H.et al. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature. 378:1995;394-398.
49. Gassmann M., Casagranda F., Orioli D.et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature. 378:1995;390-394.
50. Erickson S.L., O'Shea K.S., Ghaboosi N.et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice. Development. 124:1997;4999-5011.
51. Riethmacher D., Sonnenberg-Riethmacher E., Brinkmann V.et al. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature. 389:1997;725-730.
52. Meyer D., Yamaai T., Garratt A.et al. Isoform-specific expression and function of neuregulin. Development. 124:1997;3575-3586.
53. Britsch S., Li L., Theuring F.et al. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes Dev. 12:1998;1825-1836.
54. Murphy A.M. Contractile protein phenotypic variation during development. Cardiovasc Res. 31:1996;E25-E33.
55. Westfall M.V., Rust E.M., Metzger J.M. Slow skeletal troponin I gene transfer, expression and myofilament incorporation enhances adult cardiac myocyte contractile function. Proc Nat Acad Sci USA. 94:1997;5444-5449.
56. Moorman A.F.M., de Jong F., Denyn M.M.F., Lamers W.H. Development of the cardiac conduction system. Circ Res. 82:1998;629-644.
57. Baringa M. Tracking down mutations that can stop the heart. Science. 281:1998;32-34.
58. Schott J.J., Benson D.W., Basson C.T.et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 281:1998;108-111.
59. Lyons I., Parsons L.M., Hartley L.et al. Myogenic and morphogenesis defects in the heart tubes of murine embryos lacking the homeobox gene Nkx2-5. Genes Devel. 9:1995;1654-1666.
60. Wetzel G.T., Klitzner T.S. Developmental cardiac electrophysiology: recent advances in cellular physiology. Cardiovasc Res. 31:1996;E52-E60.
61. Baruscotti M., DiFrancesco D., Robinson R.B. A TTX-sensitive inward sodium current contributes to spontaneous activity in newborn rabbit sino-atrial node cells. J Physiol (Lond). 492:1996;21-30.
62. + channel. J Physiol (Lond). 498:1997;641-648.
63. f) in human atrial cells: implications for atrial arrhythmias. Cardiovasc Res. 38:1998;537-540.
64. Hoppe U.C., Beuckelmann D.J. Characterization of the hyperpolarization-activated inward current in isolated human atrial myocytes. Cardiovasc Res. 38:1998;788-801.
65. f, in rat ventricle cells. Pflugers Arch-Eur J Physiol. 433:1997;533-535.
66. Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature. 393:1998;587-591.
67. Mahony L. Regulation of intracellular calcium concentration in the developing heart. Cardiovasc Res. 31:1996;E61-E67.
68. Balaguru D., Haddock P.S., Puglisi J.L.et al. Role of the sarcoplasmic reticulum in contraction and relaxation of immature rabbit ventricular myocytes. J Mol Cell Cardiol. 29:1997;2747-2757.
69. Miller M.S., Friedman W.F., Wetzel G.T. Caffeine-induced contractions in developing rabbit heart. Pediatr Res. 42:1997;287-292.
70. 2+ concentration in cardiac muscle cells of early chick embryos. Devel Biol. 186:1997;177-184.
71. --free conditions in developing rabbit hearts. Am J Physiol. 273:1997;H837-H846.
72. Chin T.K., Christiansen G.A., Caldwell J.G., Thorburn J. Contribution of the sodium-calcium exchanger to contractions in immature rabbit ventricular myocytes. Pediatr Res. 41:1997;480-485.
73. Haddock P.S., Artman M., Coetzee W.A. Influence of postnatal changes in action potential duration on Na-Ca exchange in rabbit ventricular myocytes. Pflugers Arch-Eur J Physiol. 435:1998;789-795.
74. Nosek T.M., Fogaca T.H., Hatcher C.J., Brotto M.A.P., Godt R.E. Effect of cardiac neural crest ablation on contractile force and calcium uptake and release in chick heart. Am J Physiol. 273:1997;H1464-H1471.
75. Conway S.J., Godt R.E., Hatcher C.J.et al. Neural crest is involved in development of abnormal myocardial function. J Mol Cell Cardiol. 29:1997;2675-2685.
76. Kirby M.L., Gale T.F., Stewart D.E. Neural crest cells contribute to normal aorticopulmonary septation. Science. 220:1983;1059-1061.
77. Kirby M.L., Waldo K.L. Neural crest and cardiovascular patterning. Circ Res. 77:1995;211-215.
78. Kurihara Y., Kurihara H., Oda H.et al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest. 96:1995;293-300.
79. Kurihara Y., Kurihara H., Suzuki H.et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 368:1994;703-710.
80. Brand M., Le Moullec J.M., Corvol P., Gasc J.M. Ontogeny of endothelins-1 and -3, their receptors, and endothelin converting enzyme-1 in the early human embryo. J Clin Invest. 101:1998;549-559.
81. Clouthier D.E., Hosoda K., Richardson J.A.et al. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development. 125:1998;813-814.
82. Yanagisawa H., Yanagisawa M., Kapr R.P. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin-converting enzyme-1 gene. Development. 125:1998;825-836.
83. Yanagisawa H., Hammer R.E., Richardson J.A. Role of endothelin-1/endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest. 1:1998;22-33.
84. Iida K., Koseki H., Kakinuma H.et al. Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development. 124:1997;4627-4638.
85. Waldo K.L., Kumiski D., Kirby M.L. Cardiac neural crest is essential for the persistence rather than the formation of an arch artery. Dev Dynamics. 205:1996;281-292.
86. Goldmuntz E., Emanuel B.S. Genetic disorders of cardiac morphogenesis. The DiGeorge and velocardiofacial syndromes. Circ Res. 80:1997;437-443.
87. Lammer E.J., Opitz J.M. The DiGeorge anomaly as a developmental field defect. Am J Med Genet. 2:1986;113-127.
88. Kaestner K.H., Bleckmann S.C., Monaghan A.P.et al. Clustered arrangement of winged helix genes fkh-6 and MFH-1: possible implications for mesoderm development. Development. 122:1996;1751-1758.
89. Driscoll D.A., Budarf M.L., Emanuel B.S. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet. 50:1992;924-933.
90. Gong W., Emanuel B.S., Collins J.et al. A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11. Hum Mol Genet. 5:1996;789-800.
91. Galili N., Baldwin H.S., Lund J.et al. A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region. Genome Res. 7:1997;17-26.
92. Reaume A.G., de Sousa P.A., Kulkarni S.et al. Cardiac malformation in neonatal mice lacking connexin 43. Science. 267:1995;1831-1834.
93. Ewart J.L., Cohen M.F., Meyer R.A.et al. Heart and neural tube defects in transgenic mice overexpressing the Cx43 gap junction gene. Development. 124:1997;1281-1292.
94. Huang G.Y., Wessels A., Smith B.R.et al. Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart development. Dev Biol. 198:1998;32-44.
95. Srinivasan S., Baldwin H.S., Aristizabal O., Kwee L., Labow M., Artman M., Turnbull D.H. Noninvasive, in utero imaging of mouse embryonic heart development using 40 mHz echocardiography. Circulation. 98:1998;912-918.